Thrombotic microangiopathy during carfilzomib use: case series in Singapore.
Chen Y, Ooi M, Lim SF, Lin A, Lee J, Nagarajan C, et al.
Blood Cancer J. 2016;6(7):e450.
Concurrent β-thalassaemia trait and Southeast Asian ovalocytosis associated with clinically significant iron loading.
Chen Y, Law HY, Tan GP, Ang AL.
Blood Cells Mol Dis. 2016;63:25-6.
Occult recurrence of monomorphic epitheliotropic intestinal T-cell lymphoma and the role of MATK gene expression in diagnosis
Chen Y, Tan SY, Petersson BF, Khor YM, Gopalakrishnan SK, Tan D.
Hematol Oncol. 2016 Mar. doi: 10.1002/hon.2288.
The Singapore Myeloma Study Group Consensus Guidelines for the management of patients with multiple myeloma.
de Mel S, Chen Y, Gopalakrishnan SK, Ooi M, Teo C, Tan D, et al.
Singapore Med J. 2017;58(2):55-71.
Early relapse post autologous transplant is a stronger predictor of survival compared to pretreatment patient factors in the novel agent era – analysis of Singapore multiple myeloma working group
Ong SY, Widanalage SM, Chen Y, Ooi MG, Surendran S, Lin A, Koh LP, Linn YC, Ho AYL, Hwang WYK, Phipps C, Loh SMY, Goh YT, Tan D, Chng WJ, Gopalakrishnan SK.
Bone Marrow Transplant. 2016;51(7):933-7.
Lymphoproliferative Disease and Hepatitis B Reactivation: Challenges in the Era of Rapidly Evolving Targeted Therapy.
Phipps C, Chen Y, Tan D.
Clin Lymphoma Myeloma Leuk. 2016;16(1):5-11.
Daratumumab and its potential in the treatment of multiple myeloma: overview of the preclinical and clinical development.
Phipps C, Chen Y, Gopalakrishnan S, Tan D.
Ther Adv Hematol. 2015;6(3):120-7.
Subcutaneous bortezomib combined with weekly cyclophosphamide and dexamethasone is an efficient and well tolerated regime in newly diagnosed multiple myeloma.
Ong SY, Ng HY, Surendran S, Linn YC, Chen Y, Goh YT, Diong C, Gopalakrishnan SK.
Br J Haematol. 2015;169(5):754-6.
